Vertex Pharmaceuticals 통합
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionNEXT Financial Group, Inc
Latest Disclosed Ownership2,135 shares
Latest Disclosed Value $ 469,000
NEXT Financial Group, Inc reports 398.83% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On February 15, 2022 - NEXT Financial Group, Inc filed a 13F-HR form disclosing ownership of 2,135 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $468,846 USD as of December 31, 2021. The entity filed a previous 13F-HR on October 15, 2021 disclosing 428 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 398.83% during the quarter. The current value of the position is $953,982 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2022-02-15 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,135 1,707 398.83 469 501.28 0.0308
2021-10-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 428 -2,465 -85.21 78 -86.62 0.0061
2021-07-13 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,893 515 21.66 583 14.09 0.0467
2021-04-16 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,378 619 35.19 511 22.84 0.0454
2021-02-05 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,759 176 11.12 416 -3.26 0.0398
2020-10-22 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,583 -37 -2.28 430 -8.51 0.0463
2020-07-24 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,620 -14 -0.86 470 20.82 0.0548
2020-04-27 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,634 -52 -3.08 389 5.42 0.0501
2020-01-21 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,686 14 0.84 369 30.39 0.0381
2019-10-17 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,672 480 40.27 283 29.22 0.0307
2019-07-16 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,192 462 63.29 219 63.43 0.0235
2019-07-16 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 730 730 134 0.0339
2019-02-11 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -5 -100.00 0 -100.00
2018-10-09 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5 5 1 0.0005
2018-01-16 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -66 -100.00 0 -100.00
2017-11-08 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 66 5 8.20 10 25.00 0.0028
2017-07-12 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 61 -400 -86.77 8 -85.45 0.0020
2017-05-08 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 461 0 0.00 55 61.76 0.0153
2017-02-02 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 461 -100 -17.83 34 -30.61 0.0060
2016-11-01 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 561 -102 -15.38 49 -14.04 0.0088
2016-07-07 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 663 0 0.00 57 9.62 0.0181
2016-04-20 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 663 -150 -18.45 52 -49.02 0.0183
2016-02-02 2015-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 813 0 0.00 102 21.43 0.0380
2016-02-02 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 813 102
2015-10-20 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 813 0 0.00 84 -16.00 0.0301
2015-07-29 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 813 0 0.00 100 5.26 0.0345
2015-04-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 813 -50 -5.79 95 -7.77 0.0305
2015-02-10 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 863 -50 -5.48 103 0.00 0.0342
2015-02-10 2014-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 913 913 103 0.0205
2014-10-23 2014-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 913 103
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.